Aura Biosciences, Inc. (AURA)
7.195
-0.10
(-1.30%)
USD |
NASDAQ |
Apr 20, 11:20
Aura Biosciences SG&A Expense (Quarterly) : 5.34M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 9.58M |
| Olema Pharmaceuticals, Inc. | 6.864M |
| Elicio Therapeutics, Inc. | 3.762M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |